REGENERX BIOPHARMACEUTICALS, INC. — Net Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/53d6b4eb-76e7-45c6-81ad-369a17372cfb/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-1.7M | 2022-01-01 – 2022-12-31 | evidence 0001410578-23-000628 |
| FY 2021 | $-1.6M | 2021-01-01 – 2021-12-31 | evidence 0001104659-22-040167 |
| FY 2020 | $-1.5M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-030728 |
| FY 2019 | $-1.4M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-036901 |
| FY 2018 | $-2.0M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-016982 |
| FY 2017 | $286.5k | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-017995 |
| FY 2016 | $229.1k | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-017360 |
| FY 2015 | $-5.3M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-093682 |
| FY 2014 | $-2.8M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-020097 |
| FY 2013 | $-671.3k | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-020919 |
| FY 2012 | $-847.0k | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-022111 |
| FY 2011 | $-6.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-150122 |
| FY 2010 | $-5.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-150122 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
REGENERX BIOPHARMACEUTICALS, INC. — all facts · Revenue · Operating Income